Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Proceeds from Long-Term Debt Issued

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Proceeds from Long-Term Debt Issued

VYOME HOLDINGS, INC. (HIND) reported Proceeds from Long-Term Debt Issued of $430.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2021-03-12

  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-06-30 was $430.00K.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for fiscal 2020 was $430.00K, a 95.70% decline from fiscal 2019.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for fiscal 2019 was $10.00M.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for fiscal 2018 was $0.00.
  • VYOME HOLDINGS, INC. proceeds from issuance of long-term debt for fiscal 2017 was $0.00.
Period endProceeds from Issuance of Long-term Debt 3 monthProceeds from Issuance of Long-term Debt 6 monthProceeds from Issuance of Long-term Debt 9 monthProceeds from Issuance of Long-term Debt 12 month
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$0.00
derived: sum of 2 quarters · filed 2021-03-12
$430.00K
derived: sum of 3 quarters · filed 2021-03-12
$430.00K
10-K · filed 2021-03-12
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$430.00K
derived: sum of 2 quarters · filed 2020-11-06
$430.00K
10-Q · filed 2020-11-06
$430.00K
derived: sum of 4 quarters · filed 2021-03-12
2020-06-30$430.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$430.00K
10-Q · filed 2020-07-30
$430.00K
derived: sum of 3 quarters · filed 2021-03-12
$430.00K
derived: sum of 4 quarters · filed 2021-03-12
2020-03-31$0.00
10-Q · filed 2020-06-19
$0.00
derived: sum of 2 quarters · filed 2021-03-12
$0.00
derived: sum of 3 quarters · filed 2021-03-12
$0.00
derived: sum of 4 quarters · filed 2021-03-12
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$0.00
derived: sum of 2 quarters · filed 2021-03-12
$0.00
derived: sum of 3 quarters · filed 2021-03-12
$10.00M
10-K · filed 2021-03-12
2019-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$0.00
derived: sum of 2 quarters · filed 2020-11-06
$10.00M
10-Q · filed 2020-11-06
$10.00M
derived: sum of 4 quarters · filed 2020-11-06
2019-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$10.00M
10-Q · filed 2020-07-30
$10.00M
derived: sum of 3 quarters · filed 2020-07-30
$10.00M
derived: sum of 4 quarters · filed 2020-07-30
2019-03-31$10.00M
10-Q · filed 2020-06-19
$10.00M
derived: sum of 2 quarters · filed 2020-06-19
$10.00M
derived: sum of 3 quarters · filed 2020-06-19
$10.00M
derived: sum of 4 quarters · filed 2020-06-19
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$0.00
derived: sum of 2 quarters · filed 2020-02-27
$0.00
derived: sum of 3 quarters · filed 2020-02-27
$0.00
10-K · filed 2020-02-27
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
$0.00
derived: sum of 2 quarters · filed 2019-11-08
$0.00
10-Q · filed 2019-11-08
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24
$0.00
10-Q · filed 2019-07-24
2018-03-31$0.00
10-Q · filed 2019-05-10
2017-12-31$0.00
10-K · filed 2018-03-05
2016-12-31$0.00
10-K · filed 2018-03-05
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
$5.00M
10-K · filed 2018-03-05
2015-09-30$5.00M
10-Q · filed 2016-11-10
2014-12-31$4.96M
10-K · filed 2017-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36